- Home
- RANI vs GNS Comparison
RANI vs GNS Comparison
Compare RANI & GNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RANI
- GNS
- Stock Information
- Founded
- RANI 2012
- GNS 2002
- Country
- RANI United States
- GNS Singapore
- Employees
- RANI N/A
- GNS N/A
- Industry
- RANI Medicinal Chemicals and Botanical Products
- GNS Other Consumer Services
- Sector
- RANI Health Care
- GNS Real Estate
- Exchange
- RANI Nasdaq
- GNS Nasdaq
- Market Cap
- RANI 19.6M
- GNS 17.8M
- IPO Year
- RANI 2021
- GNS 2022
- Fundamental
- Price
- RANI $0.50
- GNS $0.54
- Analyst Decision
- RANI Strong Buy
- GNS
- Analyst Count
- RANI 4
- GNS 0
- Target Price
- RANI $7.75
- GNS N/A
- AVG Volume (30 Days)
- RANI 317.2K
- GNS 7.8M
- Earning Date
- RANI 08-05-2025
- GNS 04-30-2025
- Dividend Yield
- RANI N/A
- GNS N/A
- EPS Growth
- RANI N/A
- GNS N/A
- EPS
- RANI N/A
- GNS N/A
- Revenue
- RANI $1,200,000.00
- GNS $7,912,718.00
- Revenue This Year
- RANI N/A
- GNS $233.65
- Revenue Next Year
- RANI N/A
- GNS $570.20
- P/E Ratio
- RANI N/A
- GNS N/A
- Revenue Growth
- RANI N/A
- GNS N/A
- 52 Week Low
- RANI $0.46
- GNS $0.21
- 52 Week High
- RANI $4.37
- GNS $3.20
- Technical
- Relative Strength Index (RSI)
- RANI 29.91
- GNS 70.97
- Support Level
- RANI $0.51
- GNS $0.34
- Resistance Level
- RANI $0.56
- GNS $0.47
- Average True Range (ATR)
- RANI 0.04
- GNS 0.07
- MACD
- RANI 0.01
- GNS 0.01
- Stochastic Oscillator
- RANI 0.38
- GNS 60.75
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.